Toward Quantifying the Thymic Dysfunctional State in Mouse Models of Inflammatory Bowel Disease
- 1 March 2013
- journal article
- review article
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 19 (4) , 881-888
Abstract
Inflammatory bowel disease is characterized by a number of immunological alterations, not the least in the T-cell compartment. Numerous animal models of colitis have revealed aberrant thymocyte dynamics associated with skewed thymocyte development. The recent advancements in quantitative methods have proposed critical kinetic alterations in the thymocyte development during the progression of colitis. This review focuses on the aberrant thymocyte dynamics in Gαi2-deficient mice as this mouse model provides most quantitative data of the thymocyte development associated with colitis. Herein, we discuss several dynamic changes during the progression of colitis and propose a hypothesis for the underlying causes for the skewed proportions of the thymocyte populations seen in the Gαi2-deficient mice and in other mouse models of colitis.Keywords
This publication has 99 references indexed in Scilit:
- Digesting the genetics of inflammatory bowel disease: Insights from studies of autophagy risk genesInflammatory Bowel Diseases, 2012
- Animal models of IBD: linkage to human diseaseCurrent Opinion in Pharmacology, 2010
- Decision checkpoints in the thymusNature Immunology, 2010
- CXCR4 acts as a costimulator during thymic β-selectionNature Immunology, 2009
- Mechanics of T cell receptor gene rearrangementCurrent Opinion in Immunology, 2009
- Requirement of Gαi in thymic homing and early T cell developmentMolecular Immunology, 2008
- Sparse production but preferential incorporation of recently produced naïve T cells in the human peripheral poolProceedings of the National Academy of Sciences, 2008
- Unravelling the pathogenesis of inflammatory bowel diseaseNature, 2007
- Thymic selection threshold defined by compartmentalization of Ras/MAPK signallingNature, 2006
- Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cellsNature, 2006